Samantha Bednarz

发表

Abstract CT540: A phase 1 trial of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy with IL-15 superagonist in advanced head and neck cancer: Part 1 results

J. Ritz, S. Nikiforow, R. Soiffer, 2022, Cancer Research.